Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marker Therapeutics, Inc.MRKR · Entity 7609 | Chief Financial Officer | March 24, 2022 | March 29, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marker Therapeutics, Inc.
Report date March 24, 2022 · Filed March 29, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 114,436 |
Ending reported balance
After 2022-03-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-03-24 · Grant · Acquired 150,512 · Balance 150,512 F1: Represents a restricted stock unit ("RSU") award. Row 2 · 2022-03-24 · Tax withholding · Disposed 36,076 · Balance 114,436 F2: Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a restricted stock unit ("RSU") award.
F2: Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2022 Filed Mar 29, 2022 01:03 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | Tax withholdingCommon Stock | 36,076 | $0.48 | $17,489.64 |
DisclosureSEC source: 0001209191-22-021394 · doc4.xml · nonDerivative · entry 2 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,436 F2 · shares: Represents shares withheld to satisfy tax obligations with respect to the vesting of the RSUs. Read SEC document |
| March 24, 2022 Filed Mar 29, 2022 01:03 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantCommon Stock | 150,512 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-021394 · doc4.xml · nonDerivative · entry 1 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,512 F1 · shares: Represents a restricted stock unit ("RSU") award. Read SEC document |
| February 17, 2022 Filed Feb 22, 2022 22:06 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantEmployee Stock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001209191-22-011776 · doc4.xml · derivative · entry 1 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2032-02-17 F1 · derivative.exercise_date: This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 22:31 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantEmployee Stock Option (right to buy) · Derivative | 160,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0001209191-21-010285 · doc4.xml · derivative · entry 1 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-10 F1 · derivative.exercise_date: This option vests in equal monthly installments over a four year period commencing on March 10, 2021 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:39 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantEmployee Stock Option (Right to Buy) · Derivative | 127,500 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001209191-20-018534 · doc4.xml · derivative · entry 2 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,500 Underlying: Common Stock · 127,500 shares Expires 2030-03-10 F2 · derivative.exercise_date: This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. Read SEC document |
| March 10, 2020 Filed Mar 12, 2020 20:39 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantEmployee Stock Option (Right to Buy) · Derivative | 32,500 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001209191-20-018534 · doc4.xml · derivative · entry 1 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Stock · 32,500 shares Expires 2030-03-10 F1 · derivative.exercise_date: Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 21:05 UTC | Marker Therapeutics, Inc. MRKR · Entity 7609 | GrantEmployee Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $6.81 | $0.00 |
DisclosureSEC source: 0001144204-18-062322 · tv508156_4.xml · derivative · entry 1 Kim Anthony H. · CIK 0001759782 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2028-11-27 F1 · security: Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended, in connection with the execution of an employment agreement with the Company. One quarter of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal monthly installments over a three year period upon the continued employment by the Company of the Reporting Person through the vesting dates. The option exercise price is the closing price on the date of the grant, November 27, 2018. F1 · derivative.exercise_date: Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended, in connection with the execution of an employment agreement with the Company. One quarter of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal monthly installments over a three year period upon the continued employment by the Company of the Reporting Person through the vesting dates. The option exercise price is the closing price on the date of the grant, November 27, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.